Transition Bio Transition Bio is a biotechnology company that provides technologies for biomolecular condensate analysis. | ![]() Therapeutic Solutions International Therapeutic Solutions International focuses on immune modulation for the treatment of various diseases. | ![]() Trefoil Therapeutics Trefoil Therapeutics is a biotechnology company focused on leveraging its engineered fibroblast growth factor-1 protein (eFGF-1) technology platform to develop regenerative pharmacologic treatments for corneal diseases. | ||
Founding Date | Founding Date 2014 | Founding Date 2020 | Founding Date 2007 | Founding Date 2014 |
Type | Type Public | Type Private | Type Public | Type Private |
Tags | ||||
Locations | Locations Branford, US HQ | Locations Cambridge, US HQ Cambridge, GB | Locations Oceanside, US HQ | Locations San Diego, US HQ |
Employees | Employees 10 | Employees 2915% decrease | Employees 357% decrease | Employees 138% increase |
Valuation ($) | Valuation ($) 4 m | Valuation ($) N/A | Valuation ($) 3.7 m | Valuation ($) N/A |
Financial | ||||
Net income | Net income ($11m) (FY, 2025) | Net income N/A | Net income ($2.2m) (FY, 2023) | Net income N/A |
Funding | ||||
Latest funding round | Latest funding round N/A | Latest funding round $ 50m (about 4 years ago) | Latest funding round N/A | Latest funding round $ 28m (almost 7 years ago) |
Total funding raised | Total funding raised $ 20.8m | Total funding raised $ 50m | Total funding raised N/A | Total funding raised $ 33.2m |
Transition Bio is a biotechnology company that provides technologies for biomolecular condensate analysis.
View company
Therapeutic Solutions International focuses on immune modulation for the treatment of various diseases.
View company
Trefoil Therapeutics is a biotechnology company focused on leveraging its engineered fibroblast growth factor-1 protein (eFGF-1) technology platform to develop regenerative pharmacologic treatments for corneal diseases.
View company